A Population-based Analysis of Increased Incidence and Improved Survival of Testicular Cancer Patients in Iceland

References

• Annual report of The Icelandic Cancer Society, Reyk-javik, 2001.
   Google Scholar
• Osterlind A. Testikelcancer I Danmark 1943-1982. Krwftstatistik nr. 14. Ugeskr Leger 1986; 148: 418–21.
   PubMedGoogle Scholar
• Schottenfeld D, Warshauer ME, Sherlock S, Zauber AG, Leder M, Payne R. The epidemiology of testicular cancer in young adults. Am J Epidemiol 1980; 112: 232–46.
   PubMed Web of Science ®Google Scholar
• United Kingdom Testicular Cancer Study Group. Aetiology of testicular cancer, association with con-genital abnormalities, age at puberty, infertility and exercise. Br Med J 1994; 308: 1339–93.
   PubMedGoogle Scholar
• Heimdal K, Ols son H, Tretli S, Flodgren P. Borresen AL, Fossa SD. Familial testicular cancer in Norway and southern Sweden. Br J Cancer 1996; 73: 964–9.
   PubMed Web of Science ®Google Scholar
• Forman D, Oliver RT, Brett AR, Marsh SG, Moses JH, Bodmer JG, et al. Familial testicular cancer: a report of the UK family register, estimation of risk and an HLAclass 1 sib-pair analysis. Br J Cancer 1992; 65: 255–62.
   PubMed Web of Science ®Google Scholar
• Heimdal K, Fossa SD, Johansen A. Increasing incidence and changing stage distribution of testicular carcinoma in Norway 1970-1987. Br J Cancer 1990; 62: 277–8.
   Google Scholar
• Senturia YD. The epidemiology of testicular cancer. Br J Urol 1987; 60: 285–91.
   PubMedGoogle Scholar
• Osterlind A. Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982. Br J Cancer 1986; 53: 501–5.
   PubMed Web of Science ®Google Scholar
• Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, et al. High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables. J Clin Oncol 1996; 14: 2638–45.
   PubMed Web of Science ®Google Scholar
• Germa JR, Sagarra AF, Izquierdo MA, Segui MA. Sequential trials of cisplatin, vinblastin, and bleomycin and etoposide and cisplatin in disseminated nonsemino-matous germ cell tumors of the testis with a good prognosis at a single institution. Cancer 1993; 71: 796–803.
   PubMed Web of Science ®Google Scholar
• Dahl 0. Testicular carcinoma. A curable malignancy. Acta Radiol Oncol 1985; 24: 3–15.
   Google Scholar
• Einhom LH, Williams SD. Chemotherapy of dissemi-nated testicular cancer. A random prospective study. Cancer 1980; 46: 1339–44.
   Google Scholar
• Boden G, Gibb R. Radiotherapy and testicular neo-plasms. Lancet 1951; ii: 1195–7.
   Google Scholar
• Taron RE. Test for trend in lifetable analysis. Biometrika 1975; 62: 679–82.
   Web of Science ®Google Scholar
• Fossa SD, Aass N, Kaalhus 0. Testicular cancer in young Norwegians. J Surg Oncol 1988; 39: 43–6.
   Google Scholar
• Halme A, Kellokumpu L, Lehtonen T. Trends in incidence and results of treatment of testicular germ cell tumors in Finland 1972-1983. Acta Oncol 1989; 28: 777–83.
   Google Scholar
• Cancer incidence in five continents. Volume VII. IARC Sci Publ 1997; 143: i-xxxiv, 1–1240.
   Google Scholar
• Davies JM. Testicular cancer in England and Wales: some epidemiological aspects. Lancet 1981; i: 928–32.
   Google Scholar
• Hemes EH, Harstad K, Fossa SD. Changing incidence and delay of testicular cancer in southern Norway (1981-1992). Eur Urol 1996; 30: 349–57.
   Google Scholar
• Whitaker RH. Management of the undescended testis. Br J Hosp Med 1970; 4: 25–37.
   Google Scholar
• Heimdal K, Olsson H, Tretli S, Fossa SD, Borresen AL, Bishop DT. A segregation analysis of testicular cancer based on Norwegian and Swedish families. Br J Cancer 1997; 75: 1084–7.
   PubMed Web of Science ®Google Scholar
• Schultz HP, Arends J, Barlebo H, Brincker H, Stroyer-Christoffersen I, Engelholm SA, et al. Testicular carcinoma in Denmark 1976-1980. Stage and selected clinical parameters at presentation. Acta Radiol 1984; 23: 249–53.
   Google Scholar
• Kennedy BJ, Schmidt JD, Winchester DP, Peace BL, Natarajan N, Mettlin C. National survey of patterns of care for testis cancer. Cancer 1987; 60: 1921–30.
   PubMed Web of Science ®Google Scholar
• Klepp 0, Flodgren P. Maartman-Moe H, Lindholm CE, Unsgaard B, Teiqum H, et al. Early clinical stages (CS1, CS1Mk+ and CS2A) of non-seminomatous testis cancer. Value of pre and post-orchiectomy serum tumor marker information in prediction of retroperitoneal lymph node metastases. Ann Oncol 1990; 1: 281–8.
   Google Scholar
• Jacobsen GK, Barlebo H, Olsen J and the DATECA study group. Testicular germ cell tumours in Denmark 1976-80. Pathology of 1058 consecutive cases. Acta Radiol Oncol 1984; 23: 239–47.
   Google Scholar
• Fossa SD, Klepp 0, Elgjo RF. The effect of patient's delay and doctor's delay in patients with malignant germ cell tumours. Int J Androl Suppl 1981; 4: 134.
   Google Scholar
• Bosl GJ, Geller NL, Chan EYW. Stage migration and the increasing proportion of complete responders in patients with advanced germ cell tumors. Cancer Res 1988; 48: 3524–7.
   Google Scholar
• Jones WG, Appleyard I. Delay in diagnosing testicular tumours. Br Med J 1985; 290: 1550.
   PubMedGoogle Scholar
• Chilvers CE, Saunders M, Bliss JM, Nicholls J, Horwich A. Influence of delay in diagnosis on prognosis in testicular teratoma. Br J Cancer 1989; 59: 126–8.
   Google Scholar
• Saxman SB, Finsch D, Gonin R, Einhom LH. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide and cisplatin in favourable-prognosis germ-cell tumors: The Indiana University Experience. J Clin Oncol 1998; 16: 702–6.
   PubMed Web of Science ®Google Scholar
• De Wit R, Stoter G, Kaye SB, Sleijfer DT, Jones WG, ten Bokkel Huinink WW, et al. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomised study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 1997; 15: 1837–43.
   Google Scholar
• Bayley A, Warde P. Milosevic M, Gospodarowicz M. Surveillance for stage I testicular seminoma. A review. Urol Oncol 2001; 6: 139–43.
   PubMed Web of Science ®Google Scholar
• Thomas GM. Surveillance in stage I seminoma of the testis. Urol Clin North Am 1993; 20: 85–91.
   PubMed Web of Science ®Google Scholar
• Duchesne GM, Horwich A, Deamaley DP, Nicholls J, Jay G, Peckham MJ, et al. Orchidectomy alone for stage I seminoma of the testis. Cancer 1990; 65: 1115–8.
   PubMed Web of Science ®Google Scholar
• Warde P. Jewett MAS. Surveillance for stage I testicular seminoma. Is it a good option? Urol Clin North Am 1998; 25: 425–33.
   Google Scholar
• Sternberg CN. Role of primary chemotherapy in stage I and low-volume stage II nonseminomatous germ-cell testis tumors. Urol Clin North Am 1993; 20: 93–109.
   PubMed Web of Science ®Google Scholar
• Sogani PC, Whitmore WF, Jr, Herr HW. Long-term experience with orchiectomy alone in treatment of clinical stage I non-seminomatous germ cell tumour of the testis. J Urol 1988; 133: 246–9.
   Google Scholar
• Lashley DB, Lowe BA. A rational approach to managing stage I nonseminomatous germ cell cancer. Urol Clin North Am 1998; 25: 405–23.
   PubMed Web of Science ®Google Scholar
• Freedman LS, Parkinson MC, Jones WG, Oliver RT, Peckham MJ, Read G, et al. Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchiectomy alone. Lancet 1987; ii: 294–8.
   Google Scholar
• Travis LB, Curtis RE, Storm H, Hall P, Holoway E, Van Leeuwen FE, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997; 89: 1429–39.
   Google Scholar